IL151785A0 - Lipoplysaccharides (lps) extracted from escherichia coli - Google Patents

Lipoplysaccharides (lps) extracted from escherichia coli

Info

Publication number
IL151785A0
IL151785A0 IL15178501A IL15178501A IL151785A0 IL 151785 A0 IL151785 A0 IL 151785A0 IL 15178501 A IL15178501 A IL 15178501A IL 15178501 A IL15178501 A IL 15178501A IL 151785 A0 IL151785 A0 IL 151785A0
Authority
IL
Israel
Prior art keywords
lipoplysaccharides
lps
extracted
escherichia coli
escherichia
Prior art date
Application number
IL15178501A
Other languages
English (en)
Original Assignee
Pharma Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh filed Critical Pharma Zentrale Gmbh
Publication of IL151785A0 publication Critical patent/IL151785A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15178501A 2000-03-20 2001-03-20 Lipoplysaccharides (lps) extracted from escherichia coli IL151785A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10013539A DE10013539B4 (de) 2000-03-20 2000-03-20 Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen
PCT/EP2001/003153 WO2001070756A2 (de) 2000-03-20 2001-03-20 Lipopolysaccharide aus escherichia coli

Publications (1)

Publication Number Publication Date
IL151785A0 true IL151785A0 (en) 2003-04-10

Family

ID=7635468

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15178501A IL151785A0 (en) 2000-03-20 2001-03-20 Lipoplysaccharides (lps) extracted from escherichia coli

Country Status (28)

Country Link
US (1) US6833451B2 (de)
EP (1) EP1266023A2 (de)
JP (1) JP2003528175A (de)
KR (1) KR20030047878A (de)
CN (1) CN1436245A (de)
AP (1) AP2002002622A0 (de)
AU (2) AU7389901A (de)
BG (1) BG107115A (de)
BR (1) BR0109392A (de)
CA (1) CA2402544A1 (de)
CZ (1) CZ20023469A3 (de)
DE (1) DE10013539B4 (de)
EA (1) EA005217B1 (de)
EE (1) EE200200537A (de)
HK (1) HK1053148A1 (de)
HR (1) HRP20020682A2 (de)
HU (1) HUP0204540A3 (de)
IL (1) IL151785A0 (de)
IS (1) IS6517A (de)
MX (1) MXPA02009215A (de)
NO (1) NO20024480L (de)
NZ (1) NZ520968A (de)
PL (1) PL368447A1 (de)
SK (1) SK13492002A3 (de)
UA (1) UA75068C2 (de)
WO (1) WO2001070756A2 (de)
YU (1) YU71202A (de)
ZA (1) ZA200207408B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030031684A1 (en) 2001-03-30 2003-02-13 Corixa Corporation Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
DE10328669B4 (de) * 2003-06-26 2005-12-01 Pharma-Zentrale Gmbh Plasmidfreier Klon des E. coli Stammes DSM 6601
US20050191276A1 (en) * 2003-11-25 2005-09-01 Gregory Gurtner Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase
US20050238651A1 (en) * 2003-11-25 2005-10-27 Gurtner Gregory J Treatment of inflammatory bowel disease
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN100354428C (zh) * 2005-01-13 2007-12-12 丁友玲 隧道式干热灭菌设备测试用内毒素指示剂的制备方法
EP1961823B1 (de) * 2005-11-28 2024-06-12 Biomedical Research Group Inc. Verfahren zur herstellung eines lipopolysaccharids und lipopolysaccharid
WO2011133595A1 (en) 2010-04-19 2011-10-27 Massachusetts Institute Of Technology A polymer-nanostructure composition for selective molecular recognition
US20130066064A1 (en) * 2010-05-20 2013-03-14 Glaxosmithkline Biologicals S.A, Novel process
CN105137073A (zh) * 2015-08-06 2015-12-09 中国兽医药品监察所 牛布鲁氏菌胶体金抗体检测试纸条
PL432842A1 (pl) * 2020-02-10 2021-08-16 Uniwersytet Warszawski LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE
CA3171408A1 (en) * 2020-03-13 2021-09-16 Martine Caroff Detoxified lipopolysaccharides (lps), naturally non-toxic lps, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19844191A1 (de) * 1998-09-28 2000-03-30 Pharma Zentrale Gmbh Lipopolysaccharide aus Escherichia coli

Also Published As

Publication number Publication date
HRP20020682A2 (en) 2004-12-31
EP1266023A2 (de) 2002-12-18
UA75068C2 (en) 2006-03-15
EA200200997A1 (ru) 2003-04-24
EA005217B1 (ru) 2004-12-30
HK1053148A1 (zh) 2003-10-10
SK13492002A3 (sk) 2003-03-04
EE200200537A (et) 2004-04-15
WO2001070756A3 (de) 2002-05-02
PL368447A1 (en) 2005-03-21
CA2402544A1 (en) 2002-09-10
HUP0204540A3 (en) 2003-12-29
NO20024480L (no) 2002-11-20
MXPA02009215A (es) 2004-09-10
US6833451B2 (en) 2004-12-21
YU71202A (sh) 2006-01-16
WO2001070756A2 (de) 2001-09-27
JP2003528175A (ja) 2003-09-24
US20030108573A1 (en) 2003-06-12
NZ520968A (en) 2005-07-29
CN1436245A (zh) 2003-08-13
AU7389901A (en) 2001-10-03
DE10013539B4 (de) 2006-07-13
HUP0204540A2 (hu) 2003-04-28
DE10013539A1 (de) 2001-10-18
CZ20023469A3 (cs) 2003-04-16
BG107115A (bg) 2003-05-30
KR20030047878A (ko) 2003-06-18
IS6517A (is) 2002-08-21
NO20024480D0 (no) 2002-09-19
ZA200207408B (en) 2003-01-02
BR0109392A (pt) 2003-06-03
AU2001273899B2 (en) 2005-10-06
AP2002002622A0 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
GB2374756B (en) Image processing
EP1438465A4 (de) Verbesserungen von verbindungsvorrichtungen
ZA200107111B (en) Ceramic structure.
PL351065A1 (en) Screw
IL159747A0 (en) Improved lottery system
GB2365007B (en) Insulative ceramic compact
DE60228850D1 (en) Thermoplastisches transparentes acrylnitril-butadien-styrol-harz (abs-harz)
MXPA03009048A (es) Agonistas de la somatostatina.
AU2002356409A8 (en) Distributed document processing
IL151785A0 (en) Lipoplysaccharides (lps) extracted from escherichia coli
PL362643A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2001273899A1 (en) Lipopolysaccharides (LPS) extracted from escherichia coli
PL368050A1 (en) Substituted 4-aminocyclohexanols
AU150241S (en) Lollipop
GB0220887D0 (en) Image processing
GB0129141D0 (en) Screw
ZA200207552B (en) Connector.
GB0105120D0 (en) Mechanism
GB0130198D0 (en) Video processing
PL364601A1 (en) Substituted benzo-nitro-heterocycles
ZA200205139B (en) Bone screw.
GB0008655D0 (en) Video processing improvements
ZA200204226B (en) Bone screw assembly.
GB0030518D0 (en) Video processing
IL141191A0 (en) Attritor